Literature DB >> 3011847

The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.

L K McDougal, C Thornsberry.   

Abstract

We showed that most Staphylococcus aureus strains that have borderline or intermediate susceptibility to the penicillinase-resistant penicillins (PRPs) react this way because of the activity of their beta-lactamase on these antimicrobial agents. These strains produced large amounts of staphylococcal beta-lactamase that rapidly hydrolyzed penicillin and partially hydrolyzed the PRPs. Susceptibility to hydrolysis was penicillin greater than oxacillin greater than cephalothin greater than methicillin. The borderline results and the hydrolysis could be prevented by the beta-lactamase inhibitors clavulanic acid and sulbactam. For intrinsically methicillin-resistant (heteroresistant) S. aureus, the inhibitors reduced the penicillin MICs, but the strains remained resistant to all the beta-lactam antimicrobial agents, including penicillin. We conclude that the borderline in vitro susceptibility or resistance to PRPs in most of these S. aureus strains is mediated by beta-lactamase and they are not heteroresistant or intrinsically resistant. We do not know whether this in vitro resistance is expressed clinically.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011847      PMCID: PMC268732          DOI: 10.1128/jcm.23.5.832-839.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  PURIFICATION AND PROPERTIES OF THE EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS.

Authors:  M H RICHMOND
Journal:  Biochem J       Date:  1963-09       Impact factor: 3.857

2.  Inactivation of benzylpenicillin and methicillin by hospital staphylococci.

Authors:  G A AYLIFFE; M BARBER
Journal:  Br Med J       Date:  1963-07-27

3.  Further evolution of a strain of Staphylococcus aureus in vivo: evidence for significant inactivation of flucloxacillin by penicillinase.

Authors:  R W Lacey; E L Lewis
Journal:  J Med Microbiol       Date:  1975-05       Impact factor: 2.472

4.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

5.  Penicillinase production and intrinsic resistance to penicillins in methicillin-resistant cultures of Staphylococcus aureus.

Authors:  K G Dyke
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

6.  Gratuitous synthesis of beta-lactamase in Staphylococcus aureus.

Authors:  J Leggate; W H Holms
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

7.  Susceptibility of the "penicillinase-resistant" penicillins and cephalosporins to penicillinase of Staphylococcus aureus.

Authors:  R W Lacey; A Stokes
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

8.  Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria.

Authors:  I Brook; J C Coolbaugh; R I Walker
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

9.  New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors:  L K McDougal; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

10.  CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.

Authors:  J A Retsema; A R English; A E Girard
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

View more
  98 in total

1.  Disk with high oxacillin content discriminates between methicillin-resistant and borderline methicillin-susceptible Staphylococcus aureus strains in disk diffusion assays using a low salt concentration.

Authors:  A C Petersson; C Kamme; H Miörner
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Distribution of mecA among methicillin-resistant clinical staphylococcal strains isolated at hospitals in Naples, Italy.

Authors:  E Galdiero; G Liguori; M D'Isanto; N Damiano; L Sommese
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.

Authors:  H Liu; G Buescher; N Lewis; S Snyder; D Jungkind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

4.  Nonradioactive DNA probe for detection of gene for methicillin resistance in Staphylococcus aureus.

Authors:  M Ligozzi; G M Rossolini; E A Tonin; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus.

Authors:  H Liu; N Lewis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

6.  Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci.

Authors:  J G Sierra-Madero; C Knapp; C Karaffa; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

7.  Bactericidal activity of oxacillin against beta-lactamase-hyperproducing Staphylococcus aureus.

Authors:  G L Woods; P Yam
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

8.  Comparison of test systems for recognition of methicillin resistance in Staphylococcus aureus.

Authors:  R P Mouton; S L Mulders; J de Knijff; J Hermans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

Review 9.  Optimum treatment of staphylococcal infections.

Authors:  J Turnidge; M L Grayson
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

10.  Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model.

Authors:  D S Kernodle; A B Kaiser
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.